Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2006 2
2007 3
2008 4
2009 1
2010 1
2011 4
2012 9
2013 7
2014 5
2015 9
2016 8
2017 8
2018 3
2019 6
2020 7
2021 9
2022 3
2023 3
2024 4
2025 3
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Alpha-Gal-containing biologics and anaphylaxis.
Chinuki Y, Morita E. Chinuki Y, et al. Allergol Int. 2019 Jul;68(3):296-300. doi: 10.1016/j.alit.2019.04.001. Epub 2019 Apr 30. Allergol Int. 2019. PMID: 31053502 Free article. Review.
Research has shown that the principal cause of cetuximab-induced anaphylaxis is anti-oligosaccharide IgE antibodies specific for galactose-alpha-1,3-galactose (alpha-Gal) oligosaccharide present on the mouse-derived Fab portion of the cetuximab heavy chain. . …
Research has shown that the principal cause of cetuximab-induced anaphylaxis is anti-oligosaccharide IgE antibodies specific f …
Basophil Activation Test Predicts Cetuximab Anaphylaxis Severity in Alpha-Gal IgE-Positive Patients.
Kopač P, Koren A, Bidovec-Stojkovič U, Košnik M, Dejanović L, Mesti T, Strojan P, Korošec P, Ocvirk J. Kopač P, et al. Diagnostics (Basel). 2024 Jul 1;14(13):1403. doi: 10.3390/diagnostics14131403. Diagnostics (Basel). 2024. PMID: 39001293 Free PMC article.
We prospectively recruited 38 patients and evaluated sIgE to alpha-gal in all patients before the first application of cetuximab. In all alpha-gal-sensitized patients, we evaluated skin tests to meat extracts, gelatine, and cetuximab and performed BAT with alpha-gal …
We prospectively recruited 38 patients and evaluated sIgE to alpha-gal in all patients before the first application of cetuximab. In …
Nationwide pharmacovigilance data for cetuximab-induced anaphylaxis and predictive model validation using prospective specific IgE detection.
Park KH, Lee J, Beom SH, Shin SJ, Ahn JB, Kim SR, Lee JH, Park JW. Park KH, et al. World Allergy Organ J. 2021 Jun 23;14(7):100553. doi: 10.1016/j.waojou.2021.100553. eCollection 2021 Jul. World Allergy Organ J. 2021. PMID: 34257795 Free PMC article.
In a single-center study, incidence of cetuximab-induced anaphylaxis was 1.1%. Most anaphylaxis occurred at first injection (93.3%), even under pretreatment with anti-allergic drugs. ...CONCLUSIONS: Specific IgE detection of cetuximab or alpha-gal can …
In a single-center study, incidence of cetuximab-induced anaphylaxis was 1.1%. Most anaphylaxis occurred at first injec …
The Immunology of Alpha-Gal Syndrome: History, Tick Bites, IgE, and Delayed Anaphylaxis to Mammalian Meat.
Platts-Mills TAE, Gangwar RS, Workman L, Wilson JM. Platts-Mills TAE, et al. Immunol Rev. 2025 Jul;332(1):e70035. doi: 10.1111/imr.70035. Immunol Rev. 2025. PMID: 40515672 Free PMC article. Review.
The primary features of the alpha-gal syndrome (AGS) are (i) The IgE ab that are causally related to anaphylaxis with infusions of Cetuximab are specific for galactose alpha-1,3-galactose. (ii) In the USA, this IgE ab is induced by bites of the tick Amblyomma americ …
The primary features of the alpha-gal syndrome (AGS) are (i) The IgE ab that are causally related to anaphylaxis with infusions of …
Fatal anaphylaxis due to alpha-gal syndrome after initial cetuximab administration: The first forensic case report.
Wen S, Unuma K, Chinuki Y, Hikino H, Uemura K. Wen S, et al. Leg Med (Tokyo). 2021 Jul;51:101878. doi: 10.1016/j.legalmed.2021.101878. Epub 2021 Apr 7. Leg Med (Tokyo). 2021. PMID: 33892262
Patients with alpha-gal syndrome may suffer from cetuximab-induced anaphylaxis at the first administration because of developed alpha-gal-specific IgE antibodies. ...Thus, we determined that the death was caused by cetuximab-induced anaphylaxis due to …
Patients with alpha-gal syndrome may suffer from cetuximab-induced anaphylaxis at the first administration because of develope …
[Red meat allergy].
Marchal O, Allali D. Marchal O, et al. Rev Med Suisse. 2020 Apr 8;16(689):684-687. Rev Med Suisse. 2020. PMID: 32270935 Review. French.
Common allergic reactions include isolated gastrointestinal symptoms but can potentially be life-threatening with severe anaphylaxis. Diagnosis relies on a thorough clinical history, skin-prick testing and the search for specific IgE. The management of meat allergy consist …
Common allergic reactions include isolated gastrointestinal symptoms but can potentially be life-threatening with severe anaphylaxis. …
Validation of an anti-alpha-Gal IgE fluoroenzyme-immunoassay for the screening of patients at risk of severe anaphylaxis to cetuximab.
Serrier J, Davy JB, Dupont B, Clarisse B, Parienti JJ, Petit G, Khoy K, Ollivier Y, Gervais R, Mariotte D, Le Mauff B. Serrier J, et al. BMC Cancer. 2023 Jan 9;23(1):32. doi: 10.1186/s12885-023-10501-5. BMC Cancer. 2023. PMID: 36624467 Free PMC article.
BACKGROUND: The link between immediate hypersensitivity reactions (HSR) following the first cetuximab infusion and the IgE sensitization against anti-galactose-alpha-1,3-galactose (alpha-Gal) is now well-established. ...It could help avoiding cetuximab-induced HSR b …
BACKGROUND: The link between immediate hypersensitivity reactions (HSR) following the first cetuximab infusion and the IgE sensitizat …
Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose.
Chung CH, Mirakhur B, Chan E, Le QT, Berlin J, Morse M, Murphy BA, Satinover SM, Hosen J, Mauro D, Slebos RJ, Zhou Q, Gold D, Hatley T, Hicklin DJ, Platts-Mills TA. Chung CH, et al. N Engl J Med. 2008 Mar 13;358(11):1109-17. doi: 10.1056/NEJMoa074943. N Engl J Med. 2008. PMID: 18337601 Free PMC article.
RESULTS: Among 76 cetuximab-treated subjects, 25 had a hypersensitivity reaction to the drug. IgE antibodies against cetuximab were found in pretreatment samples from 17 of these subjects; only 1 of 51 subjects who did not have a hypersensitivity reaction had such a …
RESULTS: Among 76 cetuximab-treated subjects, 25 had a hypersensitivity reaction to the drug. IgE antibodies against cetuximab
85 results